Partners/Philanthropy
I spent my career in equity analysis and made some very dear friends along the way, most recently at Janus Henderson Investors. When doctors began warning us that Maxwell was not well, I left my career in a frazzled, frantic state. I tried to be strong the day I resigned from Janus, but I simply…
We put on the first symposium for Maxwell’s disease in late November and it was an overwhelming success. The many late nights of planning all came to fruition in the best way possible! The experience of having 50 brilliant scientists, from all over the world, collaborating on the cure for SLC6A1 was entirely surreal. Each…
FOR IMMEDIATE RELEASE Contact: Amber Freed, SLC6A1 Connect Email: afreed@slc6a1connect.hostusawp.com SLC6A1 Connect Partners with Dr. Steven Gray Pre-clinical lab work currently underway on gene replacement therapy to treat SLC6A1 DENVER, CO, October 2018 – SLC6A1 Connect is proud to announce a partnership with Dr. Steven Gray from UT Southwestern to develop a gene replacement therapy…
- « Previous
- 1
- 2